Skip to main content
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.07
-1.68 (-15.63%)
At close: Apr 28, 2026, 4:00 PM EDT
8.89
-0.18 (-1.98%)
Pre-market: Apr 29, 2026, 4:48 AM EDT

Artiva Biotherapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
104
Market Cap
224.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024251.00K-33.24M-99.25%
Dec 31, 202333.49M28.56M579.21%
Dec 31, 20224.93M2.93M146.30%
Dec 31, 20212.00M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Heron Therapeutics 154.90M
Fennec Pharmaceuticals 44.64M
Voyager Therapeutics 40.37M
Orchestra BioMed Holdings 33.48M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Revenue Rankings

ARTV News

More News